verona pharma doses first patients in phase b clinical trial of rpl for copd maintenance treatment  nasdaqcom hot topics etfs  smart portfolio  currencies  online broker center search see headlines for vrna view print version more from globenewswire verona pharma doses first patients in phase b clinical trial of rpl for copd maintenance treatment verona pharma receives regulatory approval to commence phase b clinical trial of rpl for copd maintenance treatment in five countries across europe verona pharma appoints dr desiree luthman as vice president of regulatory affairs referenced stocks vrna  rate it vrp  rate it verona pharma doses first patients in phase b clinical trial of rpl for copd maintenance treatment by globenewswire  july    am edt vote up a a a dose escalation trial will evaluate rpl in approximately  copd patients london july   globe newswire  verona pharma plc aimvrp nasdaqvrna verona pharma a clinicalstage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases announces today that the first patients have been dosed in a phase b clinical trial evaluating rpl as a maintenance treatment for chronic obstructive pulmonary disease copd verona pharma expects to report topline data from this trial in the second half of  rpl is a firstinclass inhaled dual inhibitor of the enzymes phosphodiesterase  and  designed to have antiinflammatory as well as bronchodilator properties and is currently in development for the treatment of copd and cystic fibrosis the fourweek doseranging trial is planned to enroll approximately  patients with copd to investigate the efficacy safety and doseresponse of nebulized rpl as a maintenance treatment for the disease the primary endpoint of this doubleblind placebocontrolled parallel group study is improvement in lung function with rpl compared to placebo as measured by fev a standard measure of exhaled breath volume used to evaluate respiratory function the trial is being performed at a number of sites across europe and is part of verona pharmas global strategic services agreement with quintilesims to provide core clinical trial services for rpl clinical development programs as well as provide additional insights to inform development and commercial strategy  dosing our first patients in this larger fourweek phase b trial is an important step forward in the evaluation of nebulized rpl as a novel therapy for copd patients with significant unmet medical needs said jananders karlsson phd ceo of verona pharma the clinical data generated to date and the mechanism of action of rpl makes it a promising firstinclass treatment option we look forward to working with patients and healthcare providers across the trial sites to gather meaningful data and insights and expect to report topline results from this study in the second half of  in previous clinical trials in patients with copd rpl has been observed to result in statistically significant improvements in lung function as compared to placebo and has shown clinically meaningful and statistically significant improvements in lung function when added to two commonly used bronchodilators as compared to either bronchodilator administered as a single agent rpl has also shown antiinflammatory effects and has been well tolerated in clinical trials about chronic obstructive pulmonary disease chronic obstructive pulmonary disease copd is a progressive respiratory disease for which there is no cure the condition damages the airways and the lungs leading to cough mucus secretion and shortness of breath impacting a persons ability to perform daily activities according to the world health organization copd is the third leading cause of death globally with  million people worldwide suffering from the disease current therapies to treat copd are aimed at reducing and controlling symptoms despite the wide availability of these therapies many copd patients continue to suffer acute periods of worsening symptoms known as exacerbations in the us alone these exacerbations are associated with approximately  million emergency department visits  hospitalizations and  deaths per year the total annual medical costs related to copd in the us were estimated to be  billion in  and are projected to rise to  billion in  about verona pharma plc verona pharma is a clinicalstage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of respiratory diseases with significant unmet medical needs verona pharmas product candidate rpl is a firstinclass inhaled dual inhibitor of the enzymes phosphodiesterase  and  that acts as both a bronchodilator and an antiinflammatory agent in a single compound verona pharma is developing rpl for the treatment of chronic obstructive pulmonary disease copd and cystic fibrosis cf and potentially asthma forwardlooking statements this press release contains forwardlooking statements all statements contained in this press release that do not relate to matters of historical fact should be considered forwardlooking statements including but not limited to statements regarding the design of the phase b clinical trial of rpl the timing of availability of topline data for the phase b clinical trial the importance of the phase b clinical trial to our development plans for rpl the potential of rpl as a promising firstinclass treatment option for copd and the value of the data and insights that may be gathered from the phase b clinical trial these forwardlooking statements are based on managements current expectations these statements are neither promises nor guarantees but involve known and unknown risks uncertainties and other important factors that may cause our actual results performance or achievements to be materially different from our expectations expressed or implied by the forwardlooking statements including but not limited to the following our limited operating history our need for additional funding to complete development and commercialization of rpl which may not be available and which may force us to delay reduce or eliminate our development or commercialization efforts the reliance of our business on the success of rpl our only product candidate under development economic political regulatory and other risks involved with international operations the lengthy and expensive process of clinical drug development which has an uncertain outcome serious adverse undesirable or unacceptable side effects associated with rpl which could adversely affect our ability to develop or commercialize rpl potential delays in enrolling patients which could adversely affect our research and development efforts we may not be successful in developing rpl for multiple indications our ability to obtain approval for and commercialize rpl in multiple major pharmaceutical markets misconduct or other improper activities by our employees consultants principal investigators and thirdparty service providers material differences between our topline data and final data our reliance on third parties including clinical investigators manufacturers and suppliers and the risks related to these parties ability to successfully develop and commercialize rpl and lawsuits related to patents covering rpl and the potential for our patents to be found invalid or unenforceable these and other important factors under the caption risk factors in our final prospectus filed with the securities and exchange commission sec on april   relating to our registration statement on form f and our other reports filed with the sec could cause actual results to differ materially from those indicated by the forwardlooking statements made in this press release any such forwardlooking statements represent managements estimates as of the date of this press release while we may elect to update such forwardlooking statements at some point in the future we disclaim any obligation to do so even if subsequent events cause our views to change these forwardlooking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release for further information please contact verona pharma plc       tel     jananders karlsson chief executive officer       infoveronapharmacom           n singer nominated adviser and uk broker       tel     aubrey powell  james white                     icr inc us media and investor enquiries         darcie robinson       tel             darcierobinsonicrinccom stephanie carrington       tel             stephaniecarringtonicrinccom           fti consulting uk media and investor enquiries       tel     simon conway  stephanie cuthbert  natalie garlandcollins       veronapharmafticonsultingcom source verona pharma plc this article appears in news headlines referenced stocks vrna vrp latest news video crews battle two fires near murphy   login please enable javascript to view the comments powered by realtidbits related stocks articles subscribe why bojangles inc stock dropped today   pm weatherford wft q loss in line revenues lag   pm yandex loses market share in spite of strong growth   pm closex signin existing nasdaqcom member log in here by signing into to the site using any of the thirdparty services above you agree to nasdaqcoms terms of use welcome back log in using your   account switch accounts highest rated articles of last week shareholders approve major structural change to top performing yatra attains leadership position in corporate travel with the mitel to acquire shoretel  quick facts miller heiman group selects calliduscloud datahug for pipeline tractor supply company reports second quarter results view all highest rated todays market activity nasdaq    ▼   djia    ▲   sp     ▼   data as of jul   try for free nasdaq livequotes platform view all upcoming earnings company expected report date aapl jul   odfl jul   fb jul   tsla aug   t jul   amzn jul   vz jul   ge jul   earnings calendar closex edit favorites enter up to  symbols separated by commas or spaces in the text box below these symbols will be available during your session for use on applicable pages update clear list closex customize your nasdaqcom experience background color selector select the background color of your choice  black  slate gray  light gray  gray blue quote search select a default target page for your quote search  realtime  after hours  premarket  news  flash quote  summary quote  interactive charts  default setting please note that once you make your selection it will apply to all future visits to nasdaqcom if at any time you are interested in reverting to our default settings please select default setting above if you have any questions or encounter any issues in changing your default settings please email isfeedbacknasdaqcom closex please confirm your selection you have selected to change your default setting for the quote search this will now be your default target page unless you change your configuration again or you delete your cookies are you sure you want to change your settings yes no closex please disable your ad blocker or update your settings to ensure that javascript and cookies are enabled so that we can continue to provide you with the firstrate market news and data youve come to expect from us closex stocks index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest atesla standard model  will cost  longrange model will cost  pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks p‘game of thrones’ this computer model predicts who will be killed off — or survive loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  verona pharma plc  product pipeline review   trends share size research report uscanada toll free home global markets direct pharmaceutical verona pharma plc  product pipeline review   verona pharma plc  product pipeline review   published by  global markets direct published date  jun  category  pharmaceutical no of pages   pages description table of content check discount global market directs pharmaceuticals report verona pharma plc product pipeline review  provides data on the verona pharma plcs research and development focus the report includes information on current developmental pipeline complete with latest updates and features on discontinued and dormant projects  this report is built using data and information sourced from global markets directs proprietary databases verona pharma plcs corporate website sec filings investor presentations and featured press releases both from verona pharma plc and industryspecific third party sources put together by global markets directs team  scope verona pharma plc brief verona pharma plc overview including business description key information and facts and its locations and subsidiaries review of current pipeline of verona pharma plc human therapeutic division overview of pipeline therapeutics across various therapy areas coverage of current pipeline molecules in various stages of drug development including the combination treatment modalities across the globe product profiles for late stage and clinical stage products of verona pharma plc with complete description of the products developmental history mechanism of action therapeutic class target and major milestones  recent updates of the verona pharma plcs pipeline in the last quarter  key discontinued and dormant projects  latest news and deals relating to the products reasons to buy evaluate verona pharma plcs strategic position with total access to detailed information on its product pipeline  assess the growth potential of verona pharma plc in its therapy areas of focus  identify new drug targets and therapeutic classes in the verona pharma plcs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas  exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps  exploit collaboration and partnership opportunities with verona pharma plc  avoid intellectual property rights related issues  explore the dormant and discontinued projects of verona pharma plc and identify potential opportunities in those areas table of contents table of contents list of tables list of figures verona pharma plc snapshot verona pharma plc overview key information key facts verona pharma plc  research and development overview key therapeutic areas verona pharma plc  pipeline review pipeline products by stage of development pipeline products  monotherapy pipeline products  outlicensed products pipeline products  partnered products verona pharma plc  pipeline products glance verona pharma plc clinical stage pipeline products phase ii productscombination treatment modalities verona pharma plc  early stage pipeline products discovery productscombination treatment modalities verona pharma plc  drug profiles naips product description mechanism of action rd progress rpl product description mechanism of action rd progress vrp product description mechanism of action rd progress verona pharma plc  pipeline products by route of administration verona pharma plc  pipeline products by mechanism of action verona pharma plc  recent pipeline updates verona pharma plc  dormant projects verona pharma plc  company statement verona pharma plc  locations and subsidiaries head office other locations  subsidiaries  appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer  list of table verona pharma plc key information verona pharma plc key facts verona pharma plc  pipeline by indication  verona pharma plc  pipeline by stage of development  verona pharma plc  monotherapy products in pipeline  verona pharma plc  outlicensed products in pipeline  verona pharma plc  partnered products in pipeline  verona pharma plc  phase ii  verona pharma plc  discovery  verona pharma plc  pipeline by route of administration  verona pharma plc  pipeline products by mechanism of action  verona pharma plc  recent pipeline updates  verona pharma plc  dormant developmental projects verona pharma plc subsidiaries  list of chart verona pharma plc  pipeline by indication  verona pharma plc  pipeline by stage of development  verona pharma plc  monotherapy products in pipeline  verona pharma plc  outlicensed products in pipeline  verona pharma plc  partnered products in pipeline  verona pharma plc  pipeline by route of administration  verona pharma plc  pipeline products by mechanism of action   make an enquiry before buying this report please fill the enquiry form below full name  your email  job title  company  phone no  pls affix country code message security code   choose license type  select user license single license user  multiple license user  do you wish to check sample of this report order a sample report have query on this report related news amgen’s repatha gets fast fda review for additional heart benefits more than  of diabetic men have erectile dysfunction trex did not sprint it walked unhackable web communication to be launched by china tetraphases antibiotic eravacycline succeeds stage clinical trial research assistance we will be happy to help you find what you need please call us or write to us  uscanada toll free tel   email  salesresearchmozus vrna stock price  verona pharma plc adr stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  col  lyb  fls  mo  sbux  gt  latest newsall times eastern a tesla standard model  will cost  longrange model will cost   updated wall street isn’t ready for a point tumble in the dow industrials  barrons buzz robo  facebook and twitter trading on news  a wild week in washington  updated the dark side of cruises  trump to police dont be too nice  updated the highest paid athletes in the world in one chart  updated oj simpson made over  while in prison and won’t have to give any of it to the goldman family  updated here are  coworkers you should avoid like the plague — especially in meetings  updated top  most annoying people you may want to unfriend on facebook to be replaced home investing quotes adrs vrna overview compare quotes market screener sectors vrna us nasdaq join td ameritrade find a broker verona pharma plc adr watchlist createvrnaalert closed last updated jul    pm cedt delayed quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume   day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee na pe ratio na eps  yield na dividend na exdividend date na short interest k   of float shorted  average volume k performance  day   month   month  recent news marketwatch other dow jones verona pharma started at outperform with  stock price target at wedbush securities verona pharma started at outperform with  stock price target at wedbush securities may   at  am et by tomi kilgore verona pharma started at buy with  stock price target at suntrust rh verona pharma started at buy with  stock price target at suntrust rh may   at  am et by tomi kilgore verona pharma started at buy with  stock price target at stifel nicolaus verona pharma started at buy with  stock price target at stifel nicolaus may   at  am et by tomi kilgore no headlines available recent news other news press releases nea management company llc buys mersana therapeutics inc snap inc sucampo pharmaceuticals  nea management company llc buys mersana therapeutics inc snap inc sucampo pharmaceuticals inc sells groupon inc aerohive networks inc jul   at  pm et on gurufocuscom verona investors still holding their breath verona investors still holding their breath jul   at  pm et on seeking alpha verona pharma vrna presents at jefferies  global healthcare conference  slideshow verona pharma vrna presents at jefferies  global healthcare conference  slideshow jun   at  pm et on seeking alpha zacks investment ideas feature highlights floor  decor holdings verona pharma emerald expositions events carvana and couldera zacks investment ideas feature highlights floor amp decor holdings verona pharma emerald expositions events carvana and couldera may   at  am et on zackscom good prospects for biotech verona pharmas thursday ipo apr   at  am et on seeking alpha verona pharma doses first patients in phase b clinical trial of rpl for copd maintenance treatment verona pharma doses first patients in phase b clinical trial of rpl for copd maintenance treatment jul   at  am et on globenewswire verona pharma receives regulatory approval to commence phase b clinical trial of rpl for copd maintenance treatment in five countries across europe verona pharma receives regulatory approval to commence phase b clinical trial of rpl for copd maintenance treatment in five countries across europe jun   at  am et on globenewswire verona pharma appoints dr desiree luthman as vice president of regulatory affairs verona pharma appoints dr desiree luthman as vice president of regulatory affairs jun   at  am et on globenewswire verona pharma initiates us clinical pharmacokinetic study for rpl following acceptance of ind application by fda verona pharma initiates us clinical pharmacokinetic study for rpl following acceptance of ind application by fda jun   at  am et on globenewswire verona pharma to present at jefferies  global healthcare conference verona pharma to present at jefferies  global healthcare conference may   at  am et on globenewswire verona pharma announces closing of exercise of underwriters overallotment option verona pharma announces closing of exercise of underwriters overallotment option may   at  pm et on globenewswire grant of options and rsus and pdmr dealings grant of options and rsus and pdmr dealings may   at  am et on globenewswire citi appointed depositary bank for verona pharma’s adr programme citi appointed depositary bank for verona pharma’s adr programme may   at  am et on businesswire  bzx verona pharma announces closing of global offering verona pharma announces closing of global offering may   at  pm et on globenewswire verona pharma announces pricing of global offering and approval to list on the nasdaq global market apr   at  pm et on globenewswire verona pharma plc adr verona pharma plc is a clinicalstage biopharmaceutical company focused on developing and commercializing innovative therapeutics for the treatment of respiratory diseases with significant unmet medical needs verona pharmas product candidate rpl is a firstinclass inhaled dual inhibitor of the enzymes phosphodiesterase  and  that acts as both a bronchodilator and an antiinflammatory agent in a single compound verona pharma is developing rpl for the treatment of chronic obstructive pulmonary disease copd cystic fibrosis and potentially asthma the company was founded by michael j a walker and clive p page on february   and is headquartered in london united kingdom see full profile analyst ratings sell under hold over buy number of ratings  full ratings benzingas top upgrades downgrades for may   may   at  am et on benzingacom competitors name chg  market cap omeros corp  m ohr pharmaceutical inc  m oncomed pharmaceuticals inc  m omni bio pharmaceutical inc  m competitor data provided by partner content trending tickers powered by dvax  s  ssti  mo  chtr  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience american depository receipt stocksa z index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies american depository receipt stocks az a currentbcdefghijklmnopqrstuvwxyzother ap  arcelarcel  azimu name country exchange sector ap moellermaersk as adr amkby united states ootc water transportshipping aac technologies holdings inc adr aacay united states ootc industrial electronics abb ltd adr abja germany xfra abb ltd adr abja germany xstu abb ltd adr abja germany xber abb ltd adr abb united states xnys industrial machinery abb ltd adr abja united states xetr industrial machinery abcam plc adr abczy united states ootc biotechnology aberdeen asset management plc adr abdny united states ootc investment advisors abertis infraestructuras sa adr abrty united states ootc transportation services accor sa adr accyy united states ootc hotels acer inc gdr acg germany xstu acer inc gdr acg germany xber acer inc gdr acid united kingdom xlon computersconsumer electronics acer inc gdr reg s aceyy united states ootc computersconsumer electronics acom co ltd adr acmuy united states ootc consumer finance acorn international inc adr atv united states xnys mixed retailing actelion ltd adr alioy united states ootc biotechnology actions semiconductor co ltd adr acts united states xnas semiconductors actividades de construccion y servicios sa adr acsay united states ootc construction adaptimmune therapeutics plc adr adap united states xnas biotechnology adaptimmune therapeutics plc adr a germany xfra biotechnology adaro energy adr adooy united states ootc coal adecco group ag adr ahexy united states ootc employmenttraining services adidas ag adr addyy united states ootc footwear adidas ag adr ads germany xstu adidas ag adr ads germany xfra adidas ag adr ads united states xetr footwear adidas ag adr ads germany xber admiral group plc adr amigy united states ootc insurance brokering adocia adr adocy united states ootc biotechnology advanced accelerator applications sa adr aaap united states xnas pharmaceuticals advanced accelerator applications sa adr vaa germany xber pharmaceuticals advanced info service pcl adr avify united states ootc wireless telecommunications services advanced semiconductor engineering inc adr asx united states xnys semiconductors advanced semiconductor engineering inc adr asxn mexico xmex semiconductors advantest corp adr ateyy united states ootc semiconductors aegon nv adr aeg united states xnys life insurance aegon nv adr aenf united states xetr life insurance aeon co ltd adr aonny united states ootc mixed retailing aeroflotrussian airlines gdr a aetg germany xfra passenger airlines aetna inc bdr aetb brazil bvmf life insurance african rainbow minerals ltd adr afrby united states ootc general mining ageas nv adr agesy united states ootc life insurance agl energy ltd adr aglny united states ootc multiutilities agria corp adr aca germany xfra farming agria corp adr gro united states xnys farming agricultural bank of china ltd adr acgby united states ootc banking agroton public ltd adr ata germany xfra farming aia group ltd adr aagiy united states ootc life insurance aiful corp adr aifly united states ootc consumer finance air china ltd adr airyy united states ootc passenger airlines air franceklm adr aflyy united states ootc passenger airlines air liquide sa adr aiquy united states ootc commodity chemicals airbus group se adr aira germany xfra airbus group se adr aira united states xetr aerospace productsparts airbus group se adr eadsy united states ootc aerospace productsparts airmedia group inc adr amcn united states xnas advertisingmarketingpublic relations aisin seiki co ltd adr aseky united states ootc auto  commercial vehicle parts aixtron se adr aixg united states xnas precision products aixtron se adr aixb germany xfra aixtron se adr aixb united states xetr precision products aixtron se adr aixb germany xstu ajinomoto co inc adr ajiny united states ootc food products akari therapeutics plc adr aktx united states xnas biotechnology akbank tas adr akb germany xstu akbank tas adr akbty united states ootc banking akbank tas adr akb germany xfra banking akzo nobel nv adr akzoy united states ootc specialty chemicals alcoa inc bdr aalc brazil bvmf aluminum alfa laval ab adr alfvy united states ootc industrial machinery algaetec ltd adr algxy united states ootc alternative fuel alibaba group holding ltd adr baba united states xnys mixed retailing alibaba group holding ltd adr ahla germany xstu alibaba group holding ltd adr ahla germany xfra alibaba group holding ltd adr ahla united states xetr mixed retailing alibaba group holding ltd adr ahla germany xhan alibaba group holding ltd adr ahla germany xber alibaba group holding ltd adr ahla germany xham alibaba group holding ltd adr ahla germany xmun alibaba group holding ltd adr ahla germany xdus alibaba group holding ltd adr baba switzerland xswx mixed retailing alibaba group holding ltd adr baban mexico xmex mixed retailing alkane resources ltd adr anlky united states ootc general mining alliance global group inc adr alggy united states ootc real estate developers allianz se adr alva germany xfra allianz se adr alva united states xetr fullline insurance allianz se adr azsey united states ootc fullline insurance allied group ltd adr aledy united states ootc diversified holding companies alpha bank ae adr albky united states ootc banking alphabet inc cl a bdr gogl brazil bvmf internetonline alphabet inc cl a cedear googl argentina xbue internetonline alphabet inc cl c bdr gogl brazil bvmf internetonline alps electric co ltd adr apely united states ootc industrial electronics alstom sa adr alsmy united states ootc railroads alumina ltd adr wmc germany xber alumina ltd adr awcmy united states ootc aluminum aluminum corp of china ltd adr ach united states xnys aluminum aluminum corp of china ltd adr achn mexico xmex aluminum aluminum corp of china ltd adr aoca germany xfra aluminum aluminum corp of china ltd adr aoca germany xber amadeus it group sa adr amady united states ootc computer services amarin corp plc adr amrn united states xnas biotechnology amarin corp plc adr eha germany xfra biotechnology amazoncom inc bdr amzo brazil bvmf mixed retailing ambev sa adr abev united states xnys alcoholic beveragesdrinks ambev sa adr amna germany xfra alcoholic beveragesdrinks ambev sa adr amna germany xmun ambev sa adr amna germany xstu ambev sa adr abevn mexico xmex alcoholic beveragesdrinks ambow education holding ltd adr amboy united states ootc employmenttraining services amec foster wheeler plc adr amfw united states xnys oil  gas productsservices amer sports oyj adr agpdy united states ootc sports goods america movil sab de cv adr amx united states xnys wireless telecommunications services america movil sab de cv cl a adr amov united states xnas wireless telecommunications services america movil sab de cv series l adr mvl germany xfra wireless telecommunications services american international group inc bdr aigb brazil bvmf fullline insurance amgen inc bdr amgn brazil bvmf biotechnology amp ltd adr amlyy united states ootc life insurance ana holdings inc adr alnpy united states ootc passenger airlines andritz ag adr adrzy united states ootc industrial machinery angang steel co ltd adr anggy united states ootc ironsteel anglo american platinum ltd adr angpy united states ootc precious metals anglo american plc adr ngloy united states ootc general mining anglo american plc adr ngld germany xfra anglo american plc adr ngld germany xmun anglo american plc adr ngld germany xstu anglo american plc adr ngld united states xetr general mining anglogold ashanti ltd au switzerland xswx gold anglogold ashanti ltd adr aod germany xfra gold anglogold ashanti ltd adr aod germany xdus anglogold ashanti ltd adr aod germany xmun anglogold ashanti ltd adr aod germany xstu anglogold ashanti ltd adr aod germany xber anglogold ashanti ltd adr au united states xnys gold anglogold ashanti ltd cufs aodc germany xfra gold anglogold ashanti ltd cufs agg australia xasx gold anheuserbusch inbev sa adr itka germany xfra alcoholic beveragesdrinks anheuserbusch inbev sa adr bud united states xnys alcoholic beveragesdrinks anheuserbusch inbev sa adr itka germany xstu anhui conch cement co ltd ahchy united states ootc building materialsproducts ansaldo sts spa adr asdoy united states ootc transportation services ansell ltd adr ansly united states ootc medical equipmentsupplies anta sports products ltd adr anpdy united states ootc footwear apple inc bdr aapl brazil bvmf computersconsumer electronics apple inc cedear aapl argentina xbue computersconsumer electronics arcelik as adr ackay united states ootc housewares arcelormittal adr mt united states xnys ironsteel arcelormittal adr mtn mexico xmex ironsteel arcelormittal cl a adr arrc germany xfra «» log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest atesla standard model  will cost  longrange model will cost  pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks p‘game of thrones’ this computer model predicts who will be killed off — or survive loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  investing news  investment articles  investing research bulletin investor alert investing mutual funds » how venezuela chaos could spark oil rally opec has failed to achieve political and economic turmoil in venezuela could fuel a rise in oil prices—something the organization of the petroleum exporting countries despite it’s efforts to cut back production hasn’t been able to do  pm july   what a constant stream of oil company spending cuts means for crude prices oil companies are sounding a recurring theme lower exploration and production spending estimates will that lead to a rally in oil prices  pm july   put your money where your mindset is socially conscious mutual funds invest in ways that can be good for society and your portfolio  pm july   most popular funds › fidelity contra quoteszigmanrealtime    vanguard  idx quoteszigmanrealtime    cgm tr focus quoteszigmanrealtime    dodge cox stock quoteszigmanrealtime    fairholme quoteszigmanrealtime    t rowe price eq inc quoteszigmanrealtime    usaa metals min quoteszigmanrealtime    exchange traded funds » a leveraged etf to consider in august a leveraged etf to consider in august  am july   benzingacom attention us drivers state lines can be danger zones for gas prices attention us drivers state lines can be danger zones for gas prices  am july   benzingacom spy  pm spdr sp  etf trust quoteszigmancomposite    exchange traded funds › powershares qqq quoteszigmancomposite    ishares russell  quoteszigmancomposite    financial sector spdr quoteszigmancomposite    energy sector spdr quoteszigmancomposite    ishares msci em mkt quoteszigmancomposite    conganativeunithtml  stocks » congainvestingstocksmainhtml  beyond tesla  stocks driving the autonomous car revolution look at these component manufacturers rather than the car companies says jeff reeves  pm july   these  highly taxed companies need congress to finally act on tax reform it wasn’t trump’s “movement” that lifted stocks late last year says jeff reeves it was the promise of lower corporate tax rates  pm july   most popular stocks › bac quoteszigmancomposite    c quoteszigmancomposite    msft quoteszigmancomposite    intc quoteszigmancomposite    csco quoteszigmancomposite    f quoteszigmancomposite    wfc quoteszigmancomposite    jpm quoteszigmancomposite    bonds » trimax media to sponsor performance marketing association brunch at affiliate summit east trimax media to sponsor performance marketing association brunch at affiliate summit east  pm july   wall street isn’t ready for a point tumble in the dow industrials the us stock market is on such a parabolic march higher that wall street investors may have forgotten what a typical daily downturn feels like anymore  pm july   bxtmubmusdm  pm us  month treasury bill quoteszigmanrealtime    bonds ›  mo treasury quoteszigmanrealtime     yr treasury quoteszigmanrealtime     yr treasury quoteszigmanrealtime     yr treasury quoteszigmanrealtime     yr treasury quoteszigmanrealtime    options » options screener  expirations  options chains  getting started congamininavinvestingoptionshtml  extremely low volatility could lead to a sharp but shortlived decline in stocks still a chart of the sp  reveals an undercurrent of bullishness says lawrence g mcmillan  pm july   who trades options the most millennial investors millennials are frequently criticized by market experts for the way they invest—or more accurately the way they’re not investing—but recent research indicates that at least some young market participants are going about things in a more sophisticated way than they’re typically given credit for  pm may   vix  pm cboe volatility index quoteszigmandelayed    options › spx quoteszigmanrealtime    djia quoteszigmanrealtime    comp quoteszigmanrealtime    rut quoteszigmandelayed    mid quoteszigmandelayed    currencies » dollar turns lower for the week following gdp report the us dollar fell on friday erasing its gains for the week after a read on economic growth came in below expectations though analysts said the beleaguered currency was potentially nearing a bottom  pm july   dollar rises from month low the us dollar rises on thursday gaining against major rivals in what analysts suggest a mild consolidation following precipitous declines over recent weeks  pm july   usdjpy  pm japanese yen quoteszigmanrealtimesampled    one us dollar buys › british pound quoteszigmanrealtimesampled    brazilian real quoteszigmanrealtimesampled    commodities » a week’s worth of stock performance—illustrated quick takes on boeing altria facebook and amazoncom plus eight others  min ago am july   shareholder alert monteverde  associates pc announces an investigation of parkway inc  pky shareholder alert monteverde  associates pc announces an investigation of parkway inc  pky  pm july   commodities › brent crude quoteszigmandelayed    heating oil quoteszigmandelayed    natural gas quoteszigmandelayed    gold quoteszigmandelayed    silver quoteszigmandelayed    platinum quoteszigmandelayed    corn quoteszigmandelayed    most popular  market extra wall street isn’t ready for a point tumble in the dow industrials  all the companies in jeff bezos’s empire in one large chart  market snapshot sp  nasdaq finish lower after amazon disappointment dow closes at record  marketwatch first take intel earnings have message for amd and nvidia ‘bring it on’  sectorwatch silicon valleys corporatecampus building boom is a cautionary tale stock screener » find your top stocks identify stocks based on criteria that you select such as price movement volume fundamentals technical behavior and industry congatoolsstockscreenerhtml  find a broker partner center » sponsored sections compare current broker offers trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest atesla standard model  will cost  longrange model will cost  pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks p‘game of thrones’ this computer model predicts who will be killed off — or survive loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  vrna stock price  verona pharma plc adr stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  col  lyb  fls  mo  sbux  gt  latest newsall times eastern a tesla standard model  will cost  longrange model will cost   updated wall street isn’t ready for a point tumble in the dow industrials  barrons buzz robo  facebook and twitter trading on news  a wild week in washington  updated the dark side of cruises  trump to police dont be too nice  updated the highest paid athletes in the world in one chart  updated oj simpson made over  while in prison and won’t have to give any of it to the goldman family  updated here are  coworkers you should avoid like the plague — especially in meetings  updated top  most annoying people you may want to unfriend on facebook to be replaced home investing quotes adrs vrna overview compare quotes market screener sectors vrna us nasdaq join td ameritrade find a broker verona pharma plc adr watchlist createvrnaalert closed last updated jul    pm cedt delayed quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume   day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee na pe ratio na eps  yield na dividend na exdividend date na short interest k   of float shorted  average volume k performance  day   month   month  recent news marketwatch other dow jones verona pharma started at outperform with  stock price target at wedbush securities verona pharma started at outperform with  stock price target at wedbush securities may   at  am et by tomi kilgore verona pharma started at buy with  stock price target at suntrust rh verona pharma started at buy with  stock price target at suntrust rh may   at  am et by tomi kilgore verona pharma started at buy with  stock price target at stifel nicolaus verona pharma started at buy with  stock price target at stifel nicolaus may   at  am et by tomi kilgore no headlines available recent news other news press releases nea management company llc buys mersana therapeutics inc snap inc sucampo pharmaceuticals  nea management company llc buys mersana therapeutics inc snap inc sucampo pharmaceuticals inc sells groupon inc aerohive networks inc jul   at  pm et on gurufocuscom verona investors still holding their breath verona investors still holding their breath jul   at  pm et on seeking alpha verona pharma vrna presents at jefferies  global healthcare conference  slideshow verona pharma vrna presents at jefferies  global healthcare conference  slideshow jun   at  pm et on seeking alpha zacks investment ideas feature highlights floor  decor holdings verona pharma emerald expositions events carvana and couldera zacks investment ideas feature highlights floor amp decor holdings verona pharma emerald expositions events carvana and couldera may   at  am et on zackscom good prospects for biotech verona pharmas thursday ipo apr   at  am et on seeking alpha verona pharma doses first patients in phase b clinical trial of rpl for copd maintenance treatment verona pharma doses first patients in phase b clinical trial of rpl for copd maintenance treatment jul   at  am et on globenewswire verona pharma receives regulatory approval to commence phase b clinical trial of rpl for copd maintenance treatment in five countries across europe verona pharma receives regulatory approval to commence phase b clinical trial of rpl for copd maintenance treatment in five countries across europe jun   at  am et on globenewswire verona pharma appoints dr desiree luthman as vice president of regulatory affairs verona pharma appoints dr desiree luthman as vice president of regulatory affairs jun   at  am et on globenewswire verona pharma initiates us clinical pharmacokinetic study for rpl following acceptance of ind application by fda verona pharma initiates us clinical pharmacokinetic study for rpl following acceptance of ind application by fda jun   at  am et on globenewswire verona pharma to present at jefferies  global healthcare conference verona pharma to present at jefferies  global healthcare conference may   at  am et on globenewswire verona pharma announces closing of exercise of underwriters overallotment option verona pharma announces closing of exercise of underwriters overallotment option may   at  pm et on globenewswire grant of options and rsus and pdmr dealings grant of options and rsus and pdmr dealings may   at  am et on globenewswire citi appointed depositary bank for verona pharma’s adr programme citi appointed depositary bank for verona pharma’s adr programme may   at  am et on businesswire  bzx verona pharma announces closing of global offering verona pharma announces closing of global offering may   at  pm et on globenewswire verona pharma announces pricing of global offering and approval to list on the nasdaq global market apr   at  pm et on globenewswire verona pharma plc adr verona pharma plc is a clinicalstage biopharmaceutical company focused on developing and commercializing innovative therapeutics for the treatment of respiratory diseases with significant unmet medical needs verona pharmas product candidate rpl is a firstinclass inhaled dual inhibitor of the enzymes phosphodiesterase  and  that acts as both a bronchodilator and an antiinflammatory agent in a single compound verona pharma is developing rpl for the treatment of chronic obstructive pulmonary disease copd cystic fibrosis and potentially asthma the company was founded by michael j a walker and clive p page on february   and is headquartered in london united kingdom see full profile analyst ratings sell under hold over buy number of ratings  full ratings benzingas top upgrades downgrades for may   may   at  am et on benzingacom competitors name chg  market cap omeros corp  m ohr pharmaceutical inc  m oncomed pharmaceuticals inc  m omni bio pharmaceutical inc  m competitor data provided by partner content trending tickers powered by dvax  s  ssti  mo  chtr  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience verona pharma  breathtaking science menu search breathtaking science developing innovative therapeutics to transform the standard of care for respiratory diseases search for better science we aim to build a strong clinical rd pipeline to target debilitating respiratory diseases our science targeting respiratory diseases with significant unmet medical needs there are millions of patients suffering globally from chronic debilitating respiratory conditions that are not well treated by existing medicines there is a real and pressing need for new treatments we are focused on developing these treatments our efficient rd outsourcing model gives us access to leading experts and organisations around the globe and our agility and focus on our core competencies provide the highest standards of preclinical and clinical development  see our product pipeline our strategy to progress projects with high commercial potential whilst delivering both nearand longterm value to our shareholders we have a clear view of the medical need and commercial potential of our novel products in global multibillion dollar markets making the right decisions now with partners and investors will help us identify the quickest and most effective route to market allowing us to potentially transform the lives of patients suffering from these debilating diseases with the returns enabling us to continue this mission into the future  find out more about us verona pharma verona pharma plc is a clinical stage biopharmaceutical company focused on the development and commercialization of innovative prescription medicines to treat respiratory diseases with significant unmet medical needs such as copd and cystic fibrosis the company is listed on the nasdaq global market in the united states under the vrna ticker and on the london stock exchange in the united kingdom under the vrpl ticker read more here about verona pharmas science and innovative theraputics latest press releases  july verona pharma doses first patients in phase b clinical trial of rpl for copd maintenance treatment london july   globe newswir…  june verona pharma receives regulatory approval to commence phase b clinical trial of rpl for copd maintenance treatment in five countries across europe london june   globe newswire  verona pharma plc aimvrp nasdaqvrna “verona pharma” a clinicalstage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases announces today regulatory approval in five european countries comprising the united kingdom germany romania bulgaria and the czech republic for a phase b doseranging trial of rpl for maintenance treatment of chronic obstructive pulmonary disease copd the trial is expected to commence in the third quarter of  with topline data expected in the second ha… press releases regulatory news webcast jefferies healthcare conference june   from  am to  am edt download current share price p   lon vrp   usd   nasdaq vrna   go to lse go to nasdaq quick links investor information board  management shareholders corporate governance financial performance contact us verona pharma plc  more london riverside london se re united kingdom e infoveronapharmacom t         see location on map email alerts registered address one central square cardiff cf fs united kingdom investor relations contact icr inc e icrveronaicrinccom t     nominated adviser and broker n singer one bartholemew lane london ecn ax t     verona pharma plc  more london riverside london se re t     e infoveronapharmacom  verona pharma plc  email alerts website terms and conditions legal information cookies site map     close home about us company overview strategy and business model board of directors senior management our science our science product pipeline unique mechanism of action clinical development clinical and scientific advisory board unmet need chronic obstructive pulmonary disease cystic fibrosis investors investor information ir contacts faqs shareholder information analyst coverage capital structure aim rule  shareholder warning shareprice information regulatory news and sec filings events and presentations corporate governance board of directors management and committees corporate social responsibility financial performance financial calendar news and media news download centre contact us verona pharma plc  more london riverside london se re t         verona pharma plc private company information  bloomberg july    am et pharmaceuticals company overview of verona pharma plc snapshot people company overview verona pharma plc a clinical stage biopharmaceutical company researches discovers and develops therapeutic drugs to treat respiratory diseases primarily in the united kingdom and north america the company’s lead product is rpl an inhaled dual inhibitor of the enzymes phosphodiesterase  and  which is in phase iia clinical trial that acts as a bronchodilator and an antiinflammatory agent for the treatment of chronic obstructive pulmonary disease cystic fibrosis and asthma verona pharma plc is based in london the united kingdom  more london riversidelondon  se reunited kingdom employees phone     wwwveronapharmacom key executives for verona pharma plc dr jananders karlsson phd chief executive officer  executive director age  total annual compensation k gbp mr piers john morgan ma aca chief financial officer age  total annual compensation k gbp dr kenneth newman phd mba md chief medical officer age  total annual compensation k gbp dr peter spargo phd senior vice president of cmc age  total annual compensation k gbp ms claire louise poll ba b juris llb asia legal counsel age  total annual compensation k gbp compensation as of fiscal year  verona pharma plc key developments verona pharma plc doses first patients in phase b clinical trial of rpl for copd maintenance treatment jul   verona pharma plc announced that the first patients have been dosed in a phase b clinical trial evaluating rpl as a maintenance treatment for chronic obstructive pulmonary disease copd verona pharma expects to report topline data from this trial in the second half of  rpl is a firstinclass inhaled dual inhibitor of the enzymes phosphodiesterase  and  designed to have antiinflammatory as well as bronchodilator properties and is currently in development for the treatment of copd and cystic fibrosis the fourweek doseranging trial is planned to enroll approximately  patients with copd to investigate the efficacy safety and doseresponse of nebulized rpl as a maintenance treatment for the disease the primary endpoint of this doubleblind placebocontrolled parallel group study is improvement in lung function with rpl compared to placebo as measured by fev a standard measure of exhaled breath volume used to evaluate respiratory function the trial is being performed at a number of sites across europe and is part of verona pharma’s global strategic services agreement with quintilesims to provide core clinical trial services for rpl clinical development programs as well as provide additional insights to inform development and commercial strategy in previous clinical trials in patients with copd rpl has been observed to result in statistically significant improvements in lung function as compared to placebo and has shown clinically meaningful and statistically significant improvements in lung function when added to two commonly used bronchodilators as compared to either bronchodilator administered as a single agent rpl has also shown antiinflammatory effects and has been well tolerated in clinical trials verona pharma plc receives regulatory approval to commence phase b clinical trial of rpl for copd maintenance treatment in five countries across europe jun   verona pharma plc announced that regulatory approval in five european countries comprising the united kingdom germany romania bulgaria and the czech republic for a phase b doseranging trial of rpl for maintenance treatment of chronic obstructive pulmonary disease copd the trial is expected to commence in the third quarter of  with topline data expected in the second half of  rpl is a firstinclass inhaled dual inhibitor of the enzymes phosphodiesterase  and  designed to have antiinflammatory as well as bronchodilator properties and is currently in development for the treatment of copd and cystic fibrosis this doubleblind placebocontrolled parallel group fourweek trial will investigate the efficacy safety and doseresponse of nebulized rpl for the maintenance treatment of copd across approximately  people with the disease in the above named countries the primary endpoint is evaluating improvement in lung function with rpl compared with placebo as measured by fev a standard measure of exhaled breath volume used to evaluate respiratory function verona pharma appoints desiree luthman as vice president of regulatory affairs jun   verona pharma plc announced the appointment of desiree luthman dds to the company’s executive team as vice president regulatory affairs throughout her career dr luthman has held regulatory positions at large global pharmaceutical and biotechnology companies including bristolmeyers squibb celgene and astrazeneca prior to joining verona pharma dr luthman directed regulatory activities related to pulmonary disease at sanofi and most recently led their regulatory team through the fda approval of dupilumab for atopic dermatitis in the united states similar private companies by industry company name region abbey pharma limited europe absynth biologics limited europe acacia pharma limited europe accentbio ltd europe aclar limited europe recent private companies transactions typedate target no transactions available in the past  months request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact verona pharma plc please visit wwwveronapharmacom company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft verona pharma plc adr  nasdaqvrna  stock quote  news  thestreet action alerts plus access aapjim cramers best stocks for charitable trust portfoliomost recent trade alert investing rules trading commandments real money access rm rules of investingjim cramers best stocks for  commandmentsstressed out stockscramers blog cramer mad money etfs futures markets much more banksbiotechretailtechpersonal financeretirementfinancial advisor centerhow to spendoptionsfixed incomevideo privacy policyterms of use  thestreet inc all rights reserved djia nasdaq sp  market data updated sign in your memberships your account account preferences alerts newsletters subscribe logout subscribe access insights and guidance from our wall street pros find the product thats right for you action alerts plus action alerts options daily swing trade income seeker quant ratings real money real money pro stocks under  top stocks trifecta stocks real money pro portfolio chairmans club compare all chatter on the street verona pharma plc adr vrna follow    nasdaq  health care jul    pm edt prev close  open  day lowhigh     wk lowhigh    volume  avg volume k exchange nasdaq shares outstanding m market cap m div  yield na na trade with jim cramer  days free latest news verona pharma doses first patients in phase b clinical trial of rpl for copd maintenance treatment verona pharma receives regulatory approval to commence phase b clinical trial of rpl for copd maintenance treatment in five countries across europe verona pharma appoints dr desiree luthman as vice president of regulatory affairs jun    am edt verona pharma initiates us clinical pharmacokinetic study for rpl following acceptance of ind application by fda jun    am edt verona pharma to present at jefferies  global healthcare conference may    am edt verona pharma announces closing of exercise of underwriters overallotment option may    pm edt grant of options and rsus and pdmr dealings may    am edt verona pharma announces closing of global offering may    pm edt from our partners verona investors still holding their breath seekingalpha correction verona pharma not assumed at piper jaffray the fly verona pharma assumed with an overweight at piper jaffray the fly verona pharma vrna presents at jefferies  global healthcare conference  slideshow seekingalpha verona pharma initiated with an outperform at wedbush the fly verona pharma initiated with a buy at suntrust the fly verona pharma initiated with a buy at stifel the fly good prospects for biotech verona pharmas thursday ipo seekingalpha trending tesla headlines this lineup of  amazing new cars for  ftc seen as set to block rite aid deal  secrets tesla doesnt want to admit ahead of its big model  party amazon alphabet and a gop failure on healthcare heres where wall street stands teslas model  arrives very soon  heres everything you need to know about this overhyped ride advertising partners  thestreet inc all rights reservedaction alerts plus is a registered trademark of thestreet inc compare brokers verona pharma  doses first patients in rpl phase b trial  traders log in email password remember forgot password  become a member for free sign up sign up new membersign up for free new customerdiscover our portfolios united states united kingdom france deutschland schweiz de suisse fr settings dynamic quotes  offon markets equities north americaeuropeasiaoceaniamiddle east» more equities indexes dow jonessp nasdaq tsx compftse » more indexes currency  forex eur  usdgbp  usdusd  jpyusd  cadaud  usd» more currencies commodities goldcrude oil wticrude oil brentsilverplatinum» more commodities news latest news companiesmarketseconomycurrency  forexcommoditiesinterest ratesbusiness leadersfinancial calendareconomic calendar listed company analyst recorumorsiposcapital markets transactionsnew contractsprofits warningsappointmentspress releaseseventscorporate actions sector news energybasic materialsindustrialsconsumer cyclicalconsumer noncyclicalfinancialshealthcaretechnologytelecommunications servicesutilities analysis all analysiscommentariesindex analysisstock trading strategiescommodity analysisforex analysis stock picks all stock picks portfolios my portfolio virtual portfolios traders portfolios european portfoliousa portfolioasian portfolio screeners market screener homefundamental analyse top investor ratingtop trading ratingtop consensusgrowth stocksyield stockslow valuations technical analysis oversold stocksoverbought stocksclose to resistancesclose to supportsaccumulation phasemost volatile stocks watchlists my watchlists watchlists top lists yield stocksgrowth stocksundervalued stocks top  flop top news most read newshot news top fundamentals top capitalizationtop yieldtop pertop consensustop fundamentals top technicals top rsiunusual volumestop gapstop stim top movers top usatop canadatop uktop germanytop europetop asia tools market screenerdynamic chartfinancial calendareconomic calendarsector researchcurrency converter our services premium accessdiscover our services traders homepage    equities    london stock exchange    verona pharma plc       gbbgsh verona pharma plc add to my list    mes dernières consultmost popular manage my lists no quotes available  gbp     verona pharma  doses first patients in phase b clinical trial of r  verona pharma  doses first patients in rpl phase b trial  verona pharma  approved for phase  trial of copd maintenance thera summarynewscalendarcompanyfinancialsconsensusrevisions news summarymost relevantall newssector newstweets verona pharma  doses first patients in rpl phase b trial    am cest send by mail  last name  name  from  to  you can enter multiple email addresses separated by commas message  required fields clinicalstage biopharmaceutical company verona pharma plc said on wednesday it has dosed its first patients for the phase b clinical trial testing rpl as a treatment for chronic obstructive pulmonary disease the fourweek dose ranging trail will enrol  patients with chronic obstructive pulmonary disease to investigate the efficacy safety and doseresponse of rpl as a maintenance treatment for the disease with the primary endpoint being the improvement in lung function with rpl compared to placebo verona pharma expects to reports its results from the trial in the second half of  dosing our first patients in this larger fourweek phase b trial is an important step forward in the evaluation of nebulized rpl as a novel therapy for chronic obstructive pulmonary disease patients with significant unmet medical needs the clinical data generated to date and the mechanism of action of rpl makes it a promising firstinclass treatment option we look forward to working with patients and healthcare providers across the trial sites to gather meaningful data and insights and expect to report topline results from this study in the second half of  said chief executive officer jananders karlsson shares in verona pharma were down  at  pence on wednesdayc  tbreak media all rights reserved provided by syndigate media inc syndigateinfo source middle east  north african newspapers  latest news on verona pharma plc  verona pharma  doses first patients in phase b clinical trial of rpl for co  verona pharma  doses first patients in rpl phase b trial  verona pharma  patent issued for drug combination of pdepde inhibitor and mu  verona pharma  approved for phase  trial of copd maintenance therapy  verona pharma  receives regulatory approval to commence phase b clinical trial  verona pharma  announces new clinical trial for inhaled lung therapy rpl  verona pharma  initiates us clinical pharmacokinetic study for rpl followi  verona pharma  pharmacokinetic clinical study initiated by verona pharma  arix bioscience  to present at jefferies  global healthcare conference in n  verona pharma  block listing application and review more news news from seekingalpha  verona investors still holding their breath financials  gbp sales   ebit   m net income   m finance   m yield   pe ratio   pe ratio  ev  sales   ev  sales  x capitalization  m more financials technical analysis trends verona pharma plc short termmidtermlong termtrendsbearishbearishbearish technical analysis income statement evolution please enable javascript in your browsers settings to use dynamic charts more financials consensus sell buy mean consensus buy number of analysts  average target price   gbp spread  average target  consensus details managers nametitlejananders karlsson chief executive officer  executive director david raymond ebsworth nonexecutive chairman piers john morgan chief financial officer kenneth b newman chief medical officer kenneth thomas cunningham nonexecutive director more about the company sector and competitors st jancapitalization m verona pharma plc amgen  celgene corporation  gilead sciences  regeneron pharmaceuticals  vertex pharmaceuticals  more results traderscom marketsnewsanalysisstock picksportfoliosscreenerswatchliststop  floptoolsour servicesabout surperformance sascontact usadvertiselegal informationsabout usstay connected facebooktwitterpartners börse aktien kurse und nachrichtenbest tweets copyright   surperformance all rights reserved slave vnapf key statistics  verona pharma plc financial ratios  marketwatch bulletin investor alert expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close verona pharma plc otc vnapf go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus verona pharma plc market closed  quotes are delayed by  min jun    pm vnapf quoteszigmandelayed   change   volume volume  quotes are delayed by  min quoteszigmandelayed previous close     change   day low day high na na  week low  week high   company description verona pharma plc is a clinicalstage biopharmaceutical company focused on developing and commercializing innovative therapeutics for the treatment of respiratory diseases with significant unmet medical needs verona pharmas product candidate rpl is a firstinclass inhaled dual inhibitor of verona pharma plc is a clinicalstage biopharmaceutical company focused on developing and commercializing innovative therapeutics for the treatment of respiratory diseases with significant unmet medical needs verona pharmas product candidate rpl is a firstinclass inhaled dual inhibitor of the enzymes phosphodiesterase  and  that acts as both a bronchodilator and an antiinflammatory agent in a single compound verona pharma is developing rpl for the treatment of chronic obstructive pulmonary disease copd cystic fibrosis and potentially asthma the company was founded by michael j a walker and clive p page on february   and is headquartered in london united kingdom valuation pe current  pe ratio with extraordinary items  price to book ratio  enterprise value to ebitda  efficiency income per employee  liquidity current ratio  quick ratio  cash ratio  profitability return on assets  return on equity  return on total capital  return on invested capital  capital structure officers and executives name age officer since title dr david raymond ebsworth   nonexecutive chairman dr jananders karlsson   chief executive officer  executive director dr kenneth b newman   chief medical officer mr vikas sinha   nonexecutive director insider actions – purchase – sale  – number of transactions  newslatestcompanyusvnapf marketwatch news on vnapf no news currently available for vnapf newsnonmarketwatchcompanyusvnapf other news on vnapf verona investors still holding their breath  pm july    seeking alpha at a glance verona pharma plc  more london riverside london london  south east se re phone   industry biotechnology sector health carelife sciences fiscal yearend  view sec filings revenue na net income m employees  annual report for vnapf newspressreleasecompanyusvnapf press releases on vnapf no news currently available for vnapf trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest atesla standard model  will cost  longrange model will cost  pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks p‘game of thrones’ this computer model predicts who will be killed off — or survive loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  vrplondon stock quote  verona pharma plc  bloomberg markets error could not add to watchlist x  watchlist verona pharma plc vrpln london gbp   as of  am edt  open  day range    volume  previous close  wk range     yr return  before its here its on the bloomberg terminal learn more open  day range    volume  previous close  wk range     yr return  ytd return  current pe ratio ttm  earnings per share gbp ttm  market cap m gbp  shares outstanding m  pricesales ttm  dividend indicated gross yield  sector health care  price change  industry pharmaceuticals biotechnology  life sciences  price change  related videos there are currently no related videos for this ticker please check back later company news press releases there are currently no news stories for this ticker please check back later  verona pharma plc verona pharma doses first patients in phase b clinical trial of rpl for copd maintenance treatment  verona pharma doses first patients in phase b clinical trial of rpl for copd maintenance treatment  cystic fibrosis therapeutics pipeline h  research report available at rnr market research  verona pharma plc verona pharma receives regulatory approval to commence phase b clinical trial of rpl for copd maintenance  verona pharma receives regulatory approval to commence phase b clinical trial of rpl for copd maintenance treatment in five  verona pharma plc verona pharma appoints dr desiree luthman as vice president of regulatory affairs  verona pharma appoints dr desiree luthman as vice president of regulatory affairs  verona pharma plc holdings in company  verona pharma plc holdings in company  hargreave hale aim vct  plc final results there are currently no press releases for this ticker please check back later profile verona pharma plc is a clinicalstage biopharmaceutical company focused on developing and commercializing innovative therapeutics for the treatment of respiratory diseases with significant unmet medical needs address  more london riversidelondon se reunited kingdom phone  website wwwveronapharmacom executives board members jananders karlsson chief executive officer piers john morgan cfofinance director desiree luthman vpregulatory affairs show more investors menu search verona pharma plc  more london riverside london se re t     e infoveronapharmacom  verona pharma plc  email alerts website terms and conditions legal information cookies site map     close home about us company overview strategy and business model board of directors senior management our science our science product pipeline unique mechanism of action clinical development clinical and scientific advisory board unmet need chronic obstructive pulmonary disease cystic fibrosis investors investor information ir contacts faqs shareholder information analyst coverage capital structure aim rule  shareholder warning shareprice information regulatory news and sec filings events and presentations corporate governance board of directors management and committees corporate social responsibility financial performance financial calendar news and media news download centre contact us verona pharma plc  more london riverside london se re t         verona pharma plc  american depositary share vrna verona pharma plc  american depositary share vrna product news news  stocknewscom     follow us stocktwits twitter verona pharma plc  american depositary share vrna product news news vrna – initiates clinical pharmacokinetic trial in the us for product candidate rpl following the acceptance of an ind by the fda the first subjects have been enrolled and dosed in the study jun    am  by stocknewscom staff product news key facts surrounding this news item vrna had returned  yeartodate leading up to today’s news versus a  return from the benchmark sp  during the same period more info about verona pharma plc – american depositary share vrna verona pharma plc a clinical stage biopharmaceutical company researches discovers and develops therapeutic drugs to treat respiratory diseases primarily in the united kingdom and north america the company’s lead product is rpl an inhaled dual phosphodiesterase  and  inhibitor which is in phase ii clinical trial for the treatment of chronic obstructive pulmonary disease cystic fibrosis and asthma verona pharma plc is based in london the united kingdom view our full vrna ticker page with ratings news and more vrna at a glance vrna current powr rating™ overall powr rating™ vrna current price   more vrna ratings data and news vrna price reaction the day of this event jun  vrna closing price vrna volume from avgleading up to this eventvrna mo returnafter this eventvrna day returnvrna day returnvrna day return vrna price chart more verona pharma plc  american depositary share vrna news view all eventdate symbol news detail start price end price change powr rating loading please wait view all vrna news page generated in  seconds vfactory  velocionet velocionet next generation plcs small inexpensive easytouse plcs programmed with vbuilder the industries most innovative programming software free download store ace branch embedded simulators software vbuilder vfactory indusoft tutorials  items –  account factory easy to build operator controls drag and drop controls to create operator control panels designed to be the easiest to use hmi software around click to download vfactory click to download vfactory viewer system requirements windows vista   or   or  bit current version  indusoft velocio plcs are now compatible with indusoft use to create powerful scadahmi controls log data and remotely access controls visit the indusoft page to learn more want something more custom all ace and branch talk modbus over usb connect our plcs to any device or application that talks modbus over usb or tie to your own custom application weve got a visual studio form example to get you started about us  contact us  store  velocio networks  to   privacy policy  terms of service vbuilder  velocionet velocionet next generation plcs small inexpensive easytouse plcs programmed with vbuilder the industries most innovative programming software free download store ace branch embedded simulators software vbuilder vfactory indusoft tutorials  items –  account builder better plc programming software graphically program in ladder logic or flow charts our instruction set is powerful compact and easy to learn click to download vbuilder manual click to download vbuilder software system requirements windows vista   or   or  bit current version  view change log click tools to learn about about us  contact us  store  velocio networks  to   privacy policy  terms of service simulators  velocionet velocionet next generation plcs small inexpensive easytouse plcs programmed with vbuilder the industries most innovative programming software free download store ace branch embedded simulators software vbuilder vfactory indusoft tutorials  items –  account simulators simulate inputs to aid development  reasons to use simulators  work on software before connecting to your sensors and actuators don’t have all your sensors and actuators yet can’t afford to take system offline for long prove it works before connecting to the real thing want to connect sensors and actuators one piece at a time with the external port option connect as many digital io sensors and actuators as you’d like and simulate all the rest switches let you select pinbypin which analog inputs you want to simulate using knobs and which you want to use real signals from input ports  learn to use plcs they’re a great training tool all io can be simulated compatible with most embedded plc we sell with a simulator an embedded branch main and embedded expansions you can simulate an entire branch system simulators can be set up to work with volt and volt analog ranges simulator  top and side views picture shows an embedded plc plugged into simulator embedded plcs sold separately knobs simulate analog inputs port f is optional switches simulate digital inputs leds display digital output state jumper sets whether gnd to v or av to av is used for analog inputs analog input port connector optional switches let you pinbypin to use knob or signal from analog input port optional digital input port connector optional decide pinbypin to use switch or wire plugged into this port for digital input digital output port connector optional connect outputs to real hardware our embedded plcs use ” spaced headers that extend from the underside of the plcs they’re designed to mate with these simulators as well as your custom hardware click to read more about embedded plcs view without embedded plc plugged in simulators esimulator data sheet esimp   d in  d out  analog in with port connectors  add     simulator compatible plcs embedded plcs are identical to their nonembedded version except that they connect to hardware using ” spaced headers instead of pluggable terminals visit the ace and branch pages to learn more about specific versions of these plcs embedded plc data sheets eace ebranch eexpansion eace  –  digital in  digital out  add eace  –  digital in  digital out  add eace v –  digital in  digital out  analog in  volt  add eace v –  digital in  digital out  analog in  volt  add ebranch  –  digital in  digital out  vlink out  add ebranch  –  digital in  digital out  vlink out  add ebranch v –  d in  d out  a in  volt  vlink out  add ebranch v –  d in  d out  a in  volt  vlink out  add eexp  –  digital in  digital out  vlink out  add eexp  –  digital in  digital out  vlink out  add eexp v –  d in  d out  analog in  volt  vlink out  add eexp v –  d in  d out  a in  volt  vlink out  add   vlink needed to connect expansion to branch main or to other branch expansions vlink   foot vlink cable  add vlink –  foot vlink cable  add vlink extender lets you space branch expansions up to  feet apart requires  vlink cables and standard cate cable these are not included vlink extender   pair  add   programming cable all ace and branch plcs use a standard usb to miniusb cable for programming like the one in the picture to the right if you’ve already got one great it’ll work fine if not be sure to add one to your cart vprog   foot programming cable  add power simulators require one v supply embedded plcs get their power from simulator v wall plugs   wall plug   volt  amp for  plc or powered terminator board  add   about us  contact us  store  velocio networks  to   privacy policy  terms of service ace  velocionet velocionet next generation plcs small inexpensive easytouse plcs programmed with vbuilder the industries most innovative programming software free download store ace branch embedded simulators software vbuilder vfactory indusoft tutorials  items –  account ace powerful pocketsized plcs better smaller cheaper awesome plc software and its free  x  x  worlds smallest plc starting at  lowest cost plc anywhere programmed with software youll enjoy using 🙂 create operator controls with awesome free hmi vbuilder rapidly create flow chart andor ladder logic applications our function set is comprehensive easy to use and powerful warnings and errors are presented in real time so there are no surprises at build innovative features subroutines break projects up into manageable chunks and allow program reuse objects isolate data and create logic components to greatly improve development efficiency maintainability reliability and reusability linked subroutines specify that multiple subroutines should use the same objects maybe you’ve got an initialization routine you’d like in one subroutine and a process you want in another they can share an object so you don’t have to pass data between the two vfactory simplicity is the name of the game we want you to get your application up and running asap plug in your programmed plc vfactory will gather your tags know which are readonly and which are writable you’re ready to fill pages with graphs numbers labels and value adjustment tools from vfactory’s simple yet powerful set of  tools we’re serious about delivering the easiest to use most productive plc software we could go on about our features but seeing is believing so check out our vbuilder and vfactory pages for information tutorials free downloads smallest footprint of any plc at ” x ” x ” ace is the smallest plc on the market it’s less than  the size of the next smallest plc enables new smaller projects ace  branch  value champions others strip down plcs to offer them at prices still higher than ace and branch we give you our very best products at the industry’s lowest prices flavors of ace ace specs power  to  vdc  ma maximum digital inputs  to  vdc digital outputs  to  vdc sinking transistor  ma max analog in  bit analog outputs  bit software configure for vdc or vdc thermocouple  differential analog inputs j k n t type or  bit ±v ±v ±v ±v ±v ±v ace data sheet ace    digital in  digital out  add ace   d in  d out  rsrs  add ace   d in  d out  therm  rsrs  add ace    digital in  digital out  add ace v   digital in  digital out  analog in  volt  add ace v   digital in  digital out  analog in  volt  add ace c   digital in  digital out  analog in  mamp  add ace v  d in  d out  a in v  therm  rs  add ace v  d in  d out  a in v  therm  rs  add ace c  d in  d out  a in ma  therm  rs  add ace v  d in  d out  a in v  rs  add ace v  d in  d out  a in v  rs  add ace c  d in  d out  a in mamp  rs  add ace v   d in  d out  a in  a out  therm  rs  add ace v   d in  d out  a in  a out  therm  rs  add ace c   d in  d out  a in  a out  therm  rs  add   terminal boards ace plcs come with small high quality springcage capture connectors they’re made for  awg wire these connectors along with built in protected inputs and transistor outputs work great for many cases but sometime you need something more we’ve got you covered larger screwtype relay optocoupled using a cable we’ll provide you wire these terminal boards to ace or branch’s io ports all terminal boards have a built in mount for mm din rail or  bolts all terminal boards connect to io with screwtype terminals  awg stranded or solid wire data sheets screwterminal relay optocoupled prefer a larger screwtype terminal termination  screw type  add need relay outputs these require a v power supply not included relaya relay  amp  add need optocoupled inputs opt  optocoupled  volt ac or dc  add opt  optocoupled  volt ac  add simulator sticks simulator stick plugs into any digital input port and lets you simulate  digital inputs use with any standard nonembedded ace branch and expansion plcs simulator stick  digital  digital switches  add power all ace and branch plcs come with a  position connector to attach to a  volt power supply connects to  gauge wire data sheets v and v wall plugs regulator if you don’t have a power supply we offer one it’ll power  plc or powered terminal board wall plug   volt  amp for  plc or powered terminator board  add if you’ve got a  volt supply and want to power up to  plcs or powered terminal boards we’ve got a regulator for that it connects to a mm din rail or  bolts regulator   to  volts in six volt supplies out  add we’ve also offer a  volt supply to use our regulator wall plug   volt an option to power regulator  add programming cable all ace and branch plcs use a standard usb to miniusb cable for programming like the one in the picture to the left if you’ve already got one great it’ll work fine be careful this isnt the usb to microusb that comes with many cell phones if not be sure to add one to your cart vprog   foot programming cable  add din rail mount all ace and branch plcs come standard with a superstrong sided adhesive strip it bonds well with painted metals plastics and glass this stuff is used to attach skyscraper windows to their frames weve been impressed with its strength adhesive underside of ace and branch plcs but what if i want to attach it to a din rail screws or bolts you’re in luck we’ve got a great addon that helps you attach your plc to a mm din rail or  screws or bolts vmount same thing just upside down its got these  hooks ace or branch underside notice these slots ace and branch have four of the slots shown in the image above to the right two aren’t visible twist vmount onto your ace or branch to attach pick which of the  orientations works best for your project once attached to your ace or branch rest the topside on your din rail then press the bottom side down itll snap in place providing a secure mount if youd prefer to mount using  screws or bolts just place you holes  apart vmount  bolt mounting diagram vmount  din rail  bolt mount  add about us  contact us  store  velocio networks  to   privacy policy  terms of service